Vector Space Biosciences (VXV) utilizes advanced language modeling and scientific data engineering pipelines to accelerate discoveries in space biosciences and precision medicine. Their focus is to benefit the space launch community by providing high-value correlation matrix datasets. While the projects appear to be in line with Shariah principles, there are concerns regarding their legitimacy due to a lack of comprehensive information.
| Category | Details | Status |
|---|---|---|
| Legitimacy | The project demonstrates some positive aspects in terms of legitimacy, such as having a clear roadmap and a brief overview of its teams. The active presence of the Founder/CEO on social media also adds credibility. However, it is important to note that the lack of documents or whitepapers explaining project details and the current inactivity on social media raise some concerns. | Grey |
| Project | Vector Space Biosciences (VXV) is a company that leverages advanced language modeling and scientific data engineering pipelines to produce datasets aimed at accelerating discoveries in space biosciences and precision medicine. Their goal is to benefit all parties involved in launching life into space. VXV, operating under Vectorspace AI, offers high-value correlation matrix datasets to researchers, enabling them to expedite data-driven innovation and discoveries through patent-protected Natural Language Processing/Natural Language Understanding (NLP/NLU) technology. By quickly testing hypotheses and running experiments with higher throughput, researchers can save time in their research loop. VXV's focus lies in advancing space biosciences research, encompassing areas such as dynamic reciprocity, extracellular matrix (ECM), blood microenvironment related to the brain ECM, exosomic cargo analysis, dormant tumor cells (DTCs), atrogenes, cardiolipin (CL), genes/proteins associated with human aging (including OPA1 and NME4), and the NDPK family of proteins, including NDPK-A, involved in Non-Homologous End Joining (NHEJ) for DNA repair. VXV ensures data provenance, governance, and lineage using Ethereum/ERC20 blockchain technology, enhancing the security of pharmaceutical research. | Passed |
| Financials | The token is not backed by any equity, thus there is no financial screening on this token. | Passed |
| Token | VXV has several use cases, including the design and generation of datasets, facilitating machine-to-machine transactions within a specialized exchange for datasets, and enabling access to datasets through the VXV wallet-enabled API key. The token also ensures on-chain data provenance, lineage, validation, and governance, allowing users to track ownership and changes to datasets immutably. Additionally, VXV provides retail subscriptions for accessing thematic and smart baskets for stocks and cryptocurrencies. The VXV wallet-enabled API offers tiered service levels and API parameters based on the amount and type of VXV held, enabling enhanced accuracy, precision, and profit. Lastly, the VXV wallet can optionally serve as a wrapped asset, tradable on a separate exchange. | Passed |
| Staking Method | The information on the staking system of VXV is currently not clear or provided in detail. | Grey |
Read the source document and verify project fundamentals.